LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)
CUSIP: N51517105
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common shares, Euro 0.12 nominal value per share
- Shares outstanding
- 26,019,256
- Total 13F shares
- 8,217,728
- Share change
- -555,217
- Total reported value
- $48,648,000
- Price per share
- $5.92
- Number of holders
- 17
- Value change
- -$5,131,867
- Number of buys
- 6
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP N51517105?
CUSIP N51517105 identifies LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N51517105:
Top shareholders of LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) as of Q3 2021
As of 30 Sep 2021,
LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,217,728 shares.
The largest 10 holders included
Novo Holdings A/S, Redmile Group, LLC, Nicholas Investment Partners, LP, Nantahala Capital Management, LLC, AXA S.A., SPHERA FUNDS MANAGEMENT LTD., Artal Group S.A., Falcon Edge Capital, LP, DAFNA Capital Management LLC, and Point72 Asset Management, L.P..
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
18
Q3 2021 holders
17
Holder diff
-1
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.